Philip S Bernard

Philip S Bernard

UNVERIFIED PROFILE

Are you Philip S Bernard?   Register this Author

Register author
Philip S Bernard

Philip S Bernard

Publications by authors named "Philip S Bernard"

Are you Philip S Bernard?   Register this Author

61Publications

2101Reads

9Profile Views

Molecular Biomarkers of Sessile Serrated Adenoma/Polyps.

Clin Transl Gastroenterol 2019 Nov 26. Epub 2019 Nov 26.

Department of Gastroenterology, University of Utah, Salt Lake City, Utah, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14309/ctg.0000000000000104DOI Listing
November 2019

A Multigene Assay Determines Risk of Recurrence in Patients with Triple-Negative Breast Cancer.

Cancer Res 2019 Jul 2;79(13):3466-3478. Epub 2019 May 2.

Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-18-3014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629024PMC
July 2019

Differences in molecular features of triple-negative breast cancers based on the age at diagnosis.

Cancer 2018 12 12;124(24):4676-4684. Epub 2018 Oct 12.

Division of Epidemiology, Department of Internal Medicine, University of Utah, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.31776
Publisher Site
http://dx.doi.org/10.1002/cncr.31776DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294689PMC
December 2018

Membrane proteins significantly restrict exosome mobility.

Biochem Biophys Res Commun 2018 07 19;501(4):1055-1059. Epub 2018 May 19.

Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT, 84112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2018.05.107DOI Listing
July 2018

Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptor.

Histopathology 2017 Jan 29;70(2):185-194. Epub 2016 Sep 29.

Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13038DOI Listing
January 2017

Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor.

Breast Cancer Res Treat 2016 Feb 4;155(3):483-90. Epub 2016 Feb 4.

Department of Laboratory Medicine and Pathology, University of British Columbia, 899 W 12th Ave, Vancouver, BC, V5Z 1M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3689-zDOI Listing
February 2016

Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival.

J Natl Cancer Inst 2015 Jul 28;107(7). Epub 2015 Apr 28.

Division of Research, Kaiser Permanente Northern California, Oakland, CA (MLK, CHK, LAH, EKW, AC, EPG, CPQJr, LHK, BJC); Huntsman Cancer Institute, University of Utah, Salt Lake City, UT (PSB, REF, IJS, CS); Associated Regional and University Pathologist Institute for Clinical and Experimental Pathology, Salt Lake City, UT (PSB, REF); Division of Epidemiology, Department of Internal Medicine, School of Medicine, University of Utah, Salt Lake City, UT (KSM, CS); Department of Preventive Medicine, University of Southern California, Los Angeles, CA (BML).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv087DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554253PMC
July 2015

Size and shape characterization of hydrated and desiccated exosomes.

Anal Bioanal Chem 2015 May 28;407(12):3285-301. Epub 2015 Mar 28.

Department of Chemical Engineering, University of Utah, 50 Central Campus Drive, Salt Lake City, UT, 84112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00216-015-8535-3DOI Listing
May 2015

Defining breast cancer intrinsic subtypes by quantitative receptor expression.

Oncologist 2015 May 23;20(5):474-82. Epub 2015 Apr 23.

Lineberger Comprehensive Cancer Center and Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, United Kingdom; Servicio de Oncología Médica, Instituto de Investigacion Sanitaria Hospital Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; Translation Genomics Unit, Vall d´Hebron Institute of Oncology, Barcelona, Spain; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Oncology, Hospital General Universitario de Elche, Alicante, Spain; Department of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, Coruña, Spain; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain; GEICAM, Madrid, Spain; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA; Department of Medicine, Washington University, St. Louis, Missouri, USA; Department of Oncology, Hospital of Prato, Istituto Toscani Tumori, Florence, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0372DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425383PMC
May 2015

Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics.

Cancer Epidemiol Biomarkers Prev 2014 May 12;23(5):714-24. Epub 2014 Feb 12.

Authors' Affiliations: Division of Epidemiology, Department of Internal Medicine; Huntsman Cancer Institute, University of Utah; The Associated Regional and University Pathologist Institute for Clinical and Experimental Pathology, Salt Lake City, Utah; and Division of Research, Kaiser Permanente Northern California, Oakland, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-13-1023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011983PMC
May 2014

Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes.

Cancer Epidemiol Biomarkers Prev 2014 May 12;23(5):725-34. Epub 2014 Feb 12.

Authors' Affiliations: Division of Research, Kaiser Permanente Northern California, Oakland, California; Department of Internal Medicine, Division of Epidemiology; Huntsman Cancer Institute, University of Utah; and The Associated Regional and University Pathologist Institute for Clinical and Experimental Pathology, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-13-1017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105204PMC
May 2014

A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard.

Mod Pathol 2013 Nov 24;26(11):1438-50. Epub 2013 May 24.

1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2013.97DOI Listing
November 2013

TRIM29 functions as a tumor suppressor in nontumorigenic breast cells and invasive ER+ breast cancer.

Am J Pathol 2012 Feb 2;180(2):839-47. Epub 2011 Dec 2.

Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT 84112-5550, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2011.10.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691328PMC
February 2012

High quality and quantity Genome-wide germline genotypes from FFPE normal tissue.

BMC Res Notes 2011 May 26;4:159. Epub 2011 May 26.

Genetic Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1756-0500-4-159DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123588PMC
May 2011

Phase II study of bortezomib and pegylated liposomal doxorubicin in the treatment of metastatic breast cancer.

Clin Breast Cancer 2010 Dec;10(6):465-70

The Lineberger Comprehensive Cancer Center, and Division of Hematology/Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CBC.2010.n.061DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830095PMC
December 2010

Distribution of molecular breast cancer subtypes in middle eastern-saudi arabian women: a pilot study.

Ultrastruct Pathol 2009 Jul-Aug;33(4):141-50

King Faisal University and King Fahd Hospital of the University, Al Khobar, Saudi Arabia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/01913120903183135DOI Listing
November 2009

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.

J Natl Cancer Inst 2009 May 12;101(10):736-50. Epub 2009 May 12.

Genetic Pathology Evaluation Centre, Vancouver Coastal Health Research Institute, British Columbia Cancer Agency, and University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnc
Publisher Site
http://dx.doi.org/10.1093/jnci/djp082DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684553PMC
May 2009

EGFR associated expression profiles vary with breast tumor subtype.

BMC Genomics 2007 Jul 31;8:258. Epub 2007 Jul 31.

Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2164-8-258DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2014778PMC
July 2007

Differentiating Ewing's sarcoma from other round blue cell tumors using a RT-PCR translocation panel on formalin-fixed paraffin-embedded tissues.

Mod Pathol 2007 Mar;20(3):397-404

Research and Development, The ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.3800755DOI Listing
March 2007

Discriminate gene lists derived from cDNA microarray profiles of limited samples permit distinguishing mesenchymal neoplasia ex vivo.

J Cancer Res Clin Oncol 2005 Mar 22;131(3):137-46. Epub 2004 Dec 22.

SAR Lab, Sarcoma Services, Department of Orthopedics, Huntsman Cancer Institute & Primary Children's Medical Center, University of Utah, Salt Lake City, UT 84112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-004-0640-1DOI Listing
March 2005

Statistical modeling for selecting housekeeper genes.

Genome Biol 2004 29;5(8):R59. Epub 2004 Jul 29.

Department of Oncological Sciences, Huntsman Cancer Institute, Salt Lake City, UT 84112, USA.

View Article

Download full-text PDF

Source
http://www.gene-quantification.com/szabo-hkg-2004.pdf
Web Search
http://genomebiology.com/2004/5/8/R59
Publisher Site
http://dx.doi.org/10.1186/gb-2004-5-8-r59DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC507884PMC
February 2005

State of the science: molecular classifications of breast cancer for clinical diagnostics.

Clin Biochem 2004 Jul;37(7):572-8

Department of Pathology, University of Utah, Salt Lake City, UT 84112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinbiochem.2004.05.002DOI Listing
July 2004

Color multiplex polymerase chain reaction for quantitative analysis of epidermal growth factor receptor genes in colorectal adenocarcinoma.

J Surg Oncol 2003 Aug;83(4):227-31

Department of Pathology, University of Utah School of Medicine, and ARUP Laboratories, Inc., Salt Lake City, Utah 84132, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jso.10272
Publisher Site
http://dx.doi.org/10.1002/jso.10272DOI Listing
August 2003

Molecular portraits and the family tree of cancer.

Nat Genet 2002 Dec;32 Suppl:533-40

Division of Hematology/Oncology, University of North Carolina at Chapel Hill, CB #7305, 3009 Old Clinic Building, Chapel Hill, North Carolina 27599, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1038/ng1038
Publisher Site
http://dx.doi.org/10.1038/ng1038DOI Listing
December 2002

Real-time PCR technology for cancer diagnostics.

Clin Chem 2002 Aug;48(8):1178-85

Department of Pathology, University of Utah School of Medicine, 30 North 1900 East, Salt Lake City 84132, USA.

View Article

Download full-text PDF

Source
August 2002

Homogeneous amplification and mutation scanning of the p53 gene using fluorescent melting curves.

Clin Chem 2002 Aug;48(8):1321-8

Idaho Technology Inc., Salt Lake City, UT 84105, USA.

View Article

Download full-text PDF

Source
August 2002